QED Bioscience, Inc. develops and manufactures novel monoclonal and polyclonal antibody products for academic, biotechnology, diagnostic and pharmaceutical research clients. Antibodies are developed using a client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. QED also specializes in custom antibody development and manufacturing services tailored to each client’s unique requirements including monoclonal and polyclonal antibody development, in vitro and in vivo monoclonal antibody production, antibody purification, and immunoassay development.